HuMOLYTE founder Dr. Sourabh Kharait will present the company’s preclinical and early clinical research on chemotherapy-induced mucositis at Microbiome 2026, highlighting the potential role of 2′-FL HMO, mucosal barrier support, and gut health during cancer treatment.

New preclinical research from MD Anderson suggests psilocybin may help prevent chemotherapy-induced peripheral neuropathy by protecting nerve cells. Here’s what the study found, how it may work, and why human trials are still needed.

The Oral Mucositis Assessment Scale (OMAS) gives researchers an objective way to measure mouth sores caused by chemotherapy and radiation therapy. Learn how OMAS scores redness and ulceration, how it differs from WHO mucositis grades, and why standardized assessment matters in cancer research.

September is one of the most powerful months for cancer awareness, honoring childhood, ovarian, prostate, thyroid, blood, and gynecologic cancers. Each ribbon tells a story, each campaign sparks conversation, and together they create a movement for education, early detection, and support.

Peripheral neuropathy is often blamed on chemotherapy, but new research suggests colorectal cancer itself may begin affecting peripheral nerves before treatment starts. A recent Nature Communications study found evidence of inflammation, myelin damage, altered lipid metabolism, and nerve dysfunction in mouse and primate models of colorectal cancer.

Chemotherapy can be physically and emotionally draining, making mental health just as important as physical recovery. From mindfulness techniques and support networks to nutrition and gentle exercise, there are ways to manage stress and enhance well-being. In this guide, we explore 10 practical coping strategies to help navigate the emotional challenges of cancer treatment with resilience and strength.

Chemo mouth is a common yet painful side effect of chemotherapy that can lead to dry mouth, sores, taste changes, and difficulty eating. Maintaining hydration and electrolyte balance is key to managing these symptoms. HuMOLYTE, an advanced electrolyte solution, supports both oral and gut health by replenishing essential electrolytes and protecting the mucosal lining. Learn how HuMOLYTE can help prevent chemo mouth and improve your overall well-being during cancer treatment.

Caring for someone with cancer can be deeply meaningful and deeply exhausting. Recognizing caregiver burnout early, sharing responsibilities, using respite care, and asking the cancer care team for support can help protect your health and make caregiving more sustainable.

New research suggests that Fusobacterium bacteria found inside some colorectal tumors may be linked to a higher risk of cancer recurrence and differences in chemotherapy benefit. Here’s what the study found—and what it means for patients.

Dr. Sourabh Kharait shares the unexpected startup journey behind HuMOLYTE, from a magnesium hydration product to a science-backed medical food for chemotherapy patients. His MedStart talk offers practical lessons on pivots, customer discovery, clinical research, funding, and finding product-market fit in life sciences.

Join Sacramento-area founders and entrepreneurs for Startup Happy Hour in Elk Grove featuring Rich Foreman, COO of IGH Naturals. This informal AMA-style event is a chance to hear candid startup lessons, ask questions, and connect with others building businesses in the region.

Considering Enterade Advanced Oncology during chemotherapy? This evidence-based review examines Enterade’s ingredients, clinical studies, cost, dosing, and limitations—and explains how alternatives such as HuMOLYTE use a different approach to supporting gastrointestinal health during cancer treatment.

Human milk oligosaccharides, or HMOs, are complex carbohydrates first identified in human milk. 2′-fucosyllactose, or 2′-FL, is one of the best studied. Adult studies show that 2′-FL can influence gut bacteria, while its effects on the intestinal barrier, immunity, and health outcomes remain under study.

Dr. Sourabh Kharait, Founder and CEO of IGH Naturals, has joined the University of Arizona as Associate Professor of Medicine and Medical Director of the Living Donor Transplant Program. The appointment builds on his transplant nephrology training at Columbia and more than two decades of experience in kidney care, clinical research, and medical nutrition.

A global review found chronic nerve pain in about four in ten people already diagnosed with chemotherapy-induced peripheral neuropathy. The estimate does not apply to every chemotherapy patient, varied widely across studies, and was based on very low-certainty evidence.

August is a vital month for spotlighting lesser-known cancer causes. This month highlights Appendix Cancer Awareness and campaigns promoting palliative care and cancer pain management. Discover why these initiatives are essential and how you can support them.

Severe chemotherapy-related mouth sores can make it difficult for children to eat and drink, require hospitalization, and sometimes lead oncology teams to reduce, delay, or discontinue treatment. A study of 200 hospitalized pediatric cancer patients shows why early reporting and supportive care matter.

A new study highlights how fructose, a common sugar found in processed foods, fuels liver tumor growth by increasing lipid production. Learn how dietary choices can impact liver cancer risk and what you can do to protect your health.

Cancer develops when normal cell growth and repair processes break down, leading to uncontrolled cell division and tumor formation. Understanding the causes and risks of cancer can help us better support ongoing research and improve outcomes for those affected.

Digital check-ins can help cancer patients track symptoms like pain, nausea, fatigue, mouth sores, appetite changes, and emotional distress between appointments. Learn how symptom tracking may improve communication with your care team and help caregivers know when to call.